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Abstract: Introduction: Aortic valve stenosis imposes a pressure overload on the left ventricle. Congestive heart failure is 
one of the complications which can appear, even years after the operation. The main questions are: why do patients still 
develop heart failure? Which types of congestive heart failure can be expected? Which factors related to it are known?  
Methods: A literature search was performed with the terms “aortic valve disease/replacement AND heart failure”. Some 
secondary references derived from their reference list were also included. The study design of the selected papers 
differed considerably. Therefore, the analysis is descriptive and concerns factors which can be related to congestive 
heart failure. Furthermore, surrogate outcomes are ejection fraction, hypertrophy, long axis ventricular function, torsion, 
left atrial indices, pressures in the left sided heart and in the pulmonary circulation as well as a number of other 
echocardiographic parameters. 
Results: It has become clear that decrease in ejection fraction, which is the most commonly used parameter, occurs late 
in the course of aortic valve stenosis, when damage to the left ventricle has already been inflicted. Several more 
sensitive imaging and Doppler parameters can demonstrate these changes earlier in the course of aortic valve stenosis. 
This damage proves to be irreversible, at least in part. This might explain the appearance of heart failure after aortic 
valve replacement. Although this type of heart failure is mostly “diastolic” in nature, a continuum with the systolic type 
probably exists, at least in patients with aortic valve stenosis.  
Conclusions: Damage to the left ventricle in patients with aortic valve stenosis can go unnoticed if ejection fraction is 
used as sole determinant of left ventricular function, for the timing of operation. Detection of more subtle changes, even 
in asymptomatic patients with severe aortic valve stenosis should lead to early replacement. This might result in less 
postoperative heart failure.  
Keywords: Calcified aortic valve stenosis, Aortic valve replacement, Diastolic heart failure, Systolic heart failure. 
INTRODUCTION 
Calcified aortic valve stenosis (AS) has a highly 
lethal course once it becomes symptomatic. Aortic 
valve replacement (AVR) is the only way to improve 
survival rate and to diminish symptoms such as 
exercise intolerance and dyspnea [1]. These symptoms 
are related to congestive heart failure (CHF). The 
improvement of survival rates and relief of symptoms of 
CHF in patients with AS are the main goals of AVR. 
However, CHF is not always prevented or cured by 
AVR. Postoperative CHF is also the most common 
reason for readmission after AVR [2], as well as the 
most common cause of death in patients with a high 
degree of myocardial fibrosis [3]. Postoperative CHF 
can be defined as symptoms of NYHA class III/IV 
during at least 4 weeks or as death in which CHF plays 
a primary or contributive role or as need for mitral 
surgery for functional mitral regurgitation (FMR), with 
exclusion of prosthesis valve endocarditis or 
thrombosis [4, 5]. An alternative definition consist of 
dyspnea, fatigue on ordinary effort, and a resting PCW 
of at least 15 mmHg. When if LVEF is above 50%, CHF 
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is considered as “diastolic” in nature [6]. This entity 
needs to be distinguished from systolic CHF [7]. 
Improvement of left ventricular (LV) ejection fraction 
(LVEF) after AVR translates into improved survival [8]. 
Nevertheless, mortality [9] and CHF [10] remain 
important events after AVR. This indicates that 
changes of the left sided heart and especially of the LV 
induced by AS are not fully reversible after AVR. It is 
reasonable to suppose that these persistent alterations 
also reflect the effect of AS on preoperative LV function 
(LVF) and structure. The factors leading to these 
irreversible changes need review. Although the LVEF is 
widely used as parameter [11], it is only a crude 
measure to estimate the systolic LVF. A normal LVEF 
is considered above 45% [12] or 50% [13], but this has 
low discriminatory power to detect diastolic changes in 
LV function [7]. In our own series, median LVEF was 
over 60%, even in octogenarian patients. Nevertheless, 
postoperative CHF has also been recorded in these 
series [9, 10]. The myocardium is not compressible. 
Hence, the subendocardial layers of a hypertrophied 
LV are pushed more inwardly, thereby squeezing the 
content in a larger degree. Therefore, one could expect 
that an LVEF of 50% already indicates a decrease in 
systolic LVF. This has its importance: myocardial 
dysfunction starts early in the course of AS and can 
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remain subclinical for some time, while LVEF still 
remains above 50%. Hence, early irreversible damage 
to the LV needs detection by more sensitive methods.  
METHODS 
For this purpose, a literature search was performed 
with the search terms “aortic valve disease AND heart 
failure” or “aortic valve replacement AND heart failure”. 
This resulted twice in a series of over 1,600 
manuscripts. Adding the term “left ventr*” in both 
resulted still in over 700 papers. The most relevant 
papers, which were included, dealt with the long-term 
effect on the changes of the heart induced by AS. 
Since mortality of unoperated AS is high on short term, 
postoperative studies with focus on LV parameters 
have been included, in order to obtain mid and long-
term effects of AVR. By comparing series over a long 
time-span, the effect of improved operative techniques 
and postoperative care have not been included in this 
manuscript, although these improvements may 
interfere with the effect of patient-related factors on the 
outcome after AVR [14]. Furthermore, papers 
concerning non-ventricular factors with an effect on 
postoperative CHF such as conduction defects, atrial 
fibrillation, coronary artery disease [10] and valve-
prosthesis-patient-mismatch [15], have not been 
included. The latter factor is somehow artificial, since 
the occurrence of mismatch has an effect in patients 
with an already decreased LVEF and much less in 
patients with normal LVF. In order to clarify these 
ventricular-related factors, some surrogates for the 
classical LVEF or clinically overt CHF have been 
scrutinized. These include the refined 
echocardiographic and catheter-based parameters.  
RESULTS 
The effect of AS can be found on the entire left 
sided heart. Parameters which could serve as marker 
for damage to the LV are found at several levels, 
including 1) the level of the LV, 2) directly related to 
this, the movements of the mitral valve, the trans-mitral 
flow, 3) the level of the left atrium (LA), and 4) the level 
of the pulmonary venous circulation (Table 1).Several 
surrogate Doppler and imaging derived terms have 
been used to describe the outcome of AVR in patients 
with AS. These are alphabetically listed in Table 2. 
These factors can also be used for the timing of AVR in 
(seemingly) asymptomatic patients.  
The Morphological Changes at the Level of the LV 
Include Hypertrophy and Fibrosis.  
Left ventricular hypertrophy (LVH) has been 
recognized as a repercussion of AS on the LV [16, 17]. 
LVH can be estimated by echocardiographic measuring 
the septal and posterior wall thickness using validated 
formula [6, 18-20] or by cardiac MRI [21]. The ratio 
between LV mass index and LV end-diastolic volume 
index increases in patients with AS [22]. Concentric 
and eccentric LVH can be distinguished and be related 
to diastolic resp. systolic CHF [7]. LVH compensates 
for overload on the LV, imposed by AS and helps
Table 1: Summary of the Effects of AS at the Different Levels of the Circulation 
At Ventricular and Mitral Level  
morphological LVH, even after correction for LVEF and CAD 
Fibrosis, irrespective of CAD and reduced LVEF 
LV strain on ECG in asymptomatic patients 
functional Stiffness / increase in LVEDP / diastolic dysfunction / impaired LV filling 
Decreased long axis LV function or low longitudinal strain [especially if LVEF is below 40%] 
Circumferential strain 
Isovolumetric contraction / relaxation time – Tei index [IRT+ICT/ejection time] 
Decrease in LVEF 
Torsion-to-shortening ratio TSR ratio 
FMR 
E, A, E‘, E/A and E/E’ 
At atrial  and pulmonary level Increase in LA volume, alone or in combination with FMR 
Increase LA pressure 
PALS, PACS 
Atrial arrhythmias / AF 
Increase in pulmonary vein pressure, A, S and D waves 
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Table 2: Definition of Surrogate Terms 
Term  Definition 
A late trans-mitral diastolic filling, additional parameter for patients with indecisive E/E’ [between 8 and 15] for LVEDP 
Ar atrial reversal wave, propagating from the left atrium to the pulmonary veins 
Deceleration time onset of lengthening to onset of diastasis 
dP/dt rate of rise of pressure in the LV  
E trans-mitral inflow, early diastolic mitral amplitudes, early filling velocity, E wave deceleration time   
E’ early mitral annular velocity [septal and lateral] 
E/A ratio between early and late LV filling velocity and hence a parameter for diastolic dysfunction; corresponds with 
prolongation of total filling time  
E/E’  parameter for LV diastolic function, representing LVEDP / LA filling pressure; combines the trans-mitral driving 
pressure and myocardial relaxation  
FMR regurgitation through the mitral valve, without structural valve disease; a consequence of LVH and LV dilatation with 
resulting tethering of chordate tendineae; the effective regurgitating orifice is at least 10mm  
ICT isovolumetric contraction time 
IRT isovolumetric relaxation time  
Longitudinal 
dysssynchrony 
maximum opposing LV wall delay in time-to-peak strain at apical view [long axis, 2 chamber and 4 chamber view] 
LAVI left atrial volume index 
LVEDD left ventricular end diastolic volume 
LVEDP left ventricular end diastolic volume  
LVEF [LVEDD – LVESV] / LVEDV where LVEDV = 100% 
LVESD left ventricular end systolic volume 
LVH left ventricular hypertrophy LVM>109g/m [females]>134g/m [males] 
LV-longitudinal strain ratio of length at contraction and initial length  
MAPSE mitral annular plane systolic excursion 
PACS peak atrial contraction strain 
PALS peak atrial longitudinal strain, at the end of the reservoir phase 
Peak D peak diastolic flow velocity in pulmonary veins, represents also diastolic LVF  
Peak LV-longit. strain peak negative value on the strain curve during the entire cardiac cycle 
S peak systolic mitral annular amplitude  
S/D ratio between the systolic and diastolic flow velocity in pulmonary veins, representing diastolic LVF  
Strain unit in change of length relative to its original length 
Strain rate strain / time  
Tei-index [ICT + IRT] / ejection time  
Torsion clockwise rotation of the apical part and counterclockwise rotation of the basal part of the heart 
Vp flow propagating velocity 
 
to maintain LVEF and wall stress [6, 19, 23, 24], at 
least in an initial phase [25]. LVH is the result of 
hypertrophy of the myocytes [24] and of fibrosis [19, 
11]. Concentric LVH is an important reason for diastolic 
dysfunction. The relaxation slows down and early 
ventricular filling has reduced. The contribution of the 
atrial contraction and hence, of the late ventricular 
filling becomes more important. Even in asymptomatic 
patients with AS, LVH continues to progress as long as 
the overload exists. LVH can be considered as 
maladaptive and not merely as compensatory in 
patients with AS [6]. LVH can lead to impaired coronary 
vasodilator reserve, LV dysfunction and symptoms of 
CHF [8]. LVH with signs of strain on ECG is associated 
with an increased risk for CHF [26]. Higher LVM is also 
associated with lower LVEF and with an increase in 
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CHF, independent from the severity of AS. Even more, 
absence of LVH in patients with critical AS is 
considered favorable.  
Fibrosis can be documented and quantified by 
cardiac MRI [8, 27, 28] as well as by biopsy [3, 29]. 
Fibrosis is the result of increase in collagen content of 
the myocardium [29] and starts at the sub-endocardium 
and affects mainly longitudinal LVF. This contributes to 
diastolic and systolic dysfunction [8, 11], LV dilatation, 
[3] and to symptoms of CHF [29]. Although, there is a 
wide overlap in degree of fibrosis between healthy 
controls a patients with AS, fibrosis is more present 
with the latter [28]. This overlap might be due to the 
wide variation in fibrosis in patients with AS and with a 
preserved LVEF. The degree of fibrosis does not 
correlate to the severity of AS, however [29]. Fibrosis 
can be considered as a maladaptive LV remodeling in 
AS [24], and is multifocal and widespread. Its presence 
predicts poor outcome, even after AVR [27]. Matrix 
metalloproteinase and their tissue inhibitors are 
involved in the remodeling of the cardiac extracellular 
matrix during overload conditions. These enzymes are 
in a delicate balance, which shifts to inhibition of matrix 
metalloproteinase during pressure overload of the 
ventricle. Finally, this results in accumulation of 
collagen [24].  
The Functional Changes of the LV Include 
Stiffness, Pressures, Isometric Contraction / 
Relaxation Time, Tei-Index, Dp/Dt, Longitudinal 
LVF, Circumferential Strain, Filling Pressures, 
Torsion-to-Shortening Ratio and Longitudinal 
Dissynchrony 
Diastolic filling of the LV is the result of the interplay 
between filling pressures and filling properties. These 
are stiffness (or the ratio between changes in pressure 
and changes in volume) and compliance (which is the 
reverse ratio). These properties are usually referred to 
as “end-diastolic”. Early filling of the LV is driven by 
suction caused by energy-dependent relaxation. This 
induces an intra-ventricular pressure gradient between 
base and apex [30]. Ischemia can decrease the 
diastolic LV function and slows the intra-ventricular 
propagation of the pressure wave with a concomitant 
reduction of apical suction. However, this propagation 
velocity can misleadingly be normal with increased LV 
filling pressures and normal LVEF. Stiffness of the LV 
can be documented in patients with AS and LVH [17]. 
This parameter can be used as a surrogate for fibrosis 
and can be derived from echocardiography while 
documentation of fibrosis requires biopsy or cardiac 
MR [24]. Concentric LVH and stiffness are important 
contributors to increased LV end-diastolic pressure or 
LVEDP [31] and to a delayed relaxation of the LV [19]. 
Changes in isoforms of titin contribute to stiffness of the 
LV wall. Titin is the largest sarcomeric protein and 
functions as a spring. It limits the range of motion of 
sarcomeres. The shorter isoform N2B is responsible for 
a higher degree of stiffness compared to the longer 
isoform N2BA. In patients with overload to the LV due 
to AS, the total content of titin does not alter, but the 
shorter isoform has increased. This increase in 
stiffness can occur in the early stage of LVH [32].  
The dP/dt ratio is the rate of pressure rise in the LV 
and a good index of LV performance. It is sensitive to 
changes in contractility, but less to changes in preload 
and not at all to changes in after load. It can be used to 
assess systolic LVF in patients with poor imaging 
quality [33]. Determination of LVEDP can confirm the 
diagnosis of diastolic LV dysfunction as wells as of the 
presence of CHF in symptomatic patients with 
preserved LVEF. LVEDP rises before LA pressure 
does. This is the consequence of diastolic LV 
dysfunction [34] and is the first hemodynamic 
abnormality. LVEDP is related to the pulmonary 
capillary wedge pressure and LA pressure, which are 
not the same, however. Rise in LA pressure occurs in a 
more advanced stage of the disease. The is volumetric 
contraction time (ICT) increases in patients with AS, 
but only in severe cases. This points to a slower 
systolic contraction. A prolonged effort of the LV can 
present itself as a delayed peak of contraction. 
Subendocardial ischemia can be a possible 
mechanism [25]. The isovolumetric relaxation time 
(IRT) can also be estimated by echocardiography [12]. 
The Tei-index is the sum of ICR plus ICT divided by 
ejection time. It analyses global LVF and is rather 
independent from heart rate, systolic and diastolic 
blood pressure [33]. It is a sensitive parameter for CHF. 
Change in any of the three parameters contributes to 
the change in the Tei-index. This index decreases in 
patients with AS with diastolic dysfunction but 
preserved LVEF since IRT shortens and ejection time 
is prolonged. In contrast, the Tei-index is increased in 
patients with AS and decreased LVEF, because ICT is 
prolonged and ejection time has shortened. This index 
distinguishes between normal and decreased LVF in 
patients with symptomatic AS, with high sensitivity and 
specificity [34, 35]. The Tei-index cannot be used in 
patients with atrial fibrillation, arrhythmias and 
conduction defects [33], conditions which are not rare 
in patients with AS. 
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Torsion is a shear deformation and is caused by the 
counterclockwise rotation of the apical part of the LV 
while the basal part rotates clockwise, from apical point 
of view. Torsion is due to the spiral arrangement of the 
myocardial fibers. All fibers experience the same force, 
but the epicardial fibers have a larger lever arm. 
Torsion contributes to the systolic thickening of the LV 
wall and to ejection of blood [36]. Untwisting starts late 
in the systole and occurs mostly during the RT period 
on ECG and ends at the mitral opening. Decreased 
untwisting is related to a decreased diastolic LV 
function. The torsion-to-shortening ratio (TSR) is 
consistent during systole. A uniform shortening of 
cardiac fibers is maintained by the relation between 
torsion and ejection. A change of TSR indicates 
differences in trans-mural fiber contractions, caused by 
subendocardial ischemia in patients with AS. The peak 
systolic twist and the peak apical rotation of the LV 
increase proportionally with the severity of AS: 
subendocardial ischemia results in loss of the inhibiting 
effect of the subendocardial fibers [36-39]. Stiffening of 
the valvular plane as well as LVH might result in a 
decrease in basal rotation, with a compensatory 
increase in apical rotation, in order to maintain LVEF 
[37]. Concentric LVH itself also leads to an increased 
torsion. AS also leads to a delay in relaxation and to a 
delay in the reverse of the apical twist [36]. Torsion 
during systole results in coiling and storing of energy in 
the LV. This energy is released during isovolumetric 
relaxation and results in a suction and rapid filling of 
the LV [36]. A change in TSR might be an additional 
parameter to estimate the stage of AS in patient with 
still preserved LVEF.  
Longitudinal LVF is determined by longitudinally 
oriented fibers. These are located subendocardially 
and hence are vulnerable to ischemia, resulting in 
contractile and relaxation abnormalities [12, 17]. AS 
selectively decreases longitudinal LVF and strain 
[40,41]. Longitudinal LVF is not well reflected by LVEF, 
since the latter remains normal for a longer time 
[17,40,42]. Hence, longitudinal LVF is more sensitive in 
detecting myocardial damage [11]. Longitudinal systolic 
LVF also correlates with fibrosis [43]. Long axis LVF is 
very sensitive in early documenting myocardial 
abnormalities in patients with AS [43]. In order to 
preserve LVEF, circumferential and rotational strain 
increase as compensation. Increased torsion of the LV 
during systole might also be helpful herein [11]. 
Circumferential strainis more affected by aortic valve 
regurgitation and less by AS, while longitudinal strain is 
most affected by AS [44]. Although increased 
circumferential strain compensates for a decreased 
longitudinal strain to maintain LVEF, in patients with 
severely decreased LVF, this compensation is lost [39, 
40]. Longitudinal dyssynchrony is an important 
contributing mechanism in the progression of CHF and 
of LV remodeling [11]. LVH and fibrosis can lead to 
distorted electrical activation and hence impaired LV 
filling [45]. Non-uniformity in the damage of 
cardiomyocytes may lead to dyssynchrony and non-
uniform regional LV dysfunction. Longitudinal 
dyssynchrony has an adverse effect on diastolic and 
systolic LVF as well as on LA and right ventricular 
function. Radial and circumferential strain seems to be 
less affected. Time course indicates that with 
increasing severity of AS, longitudinal LV dysfunction 
leads to and predicts dyssynchrony [11].  
The Changes at the Mitral Level Includes Mitral 
Annular Displacement and the Related Parameters 
as Well as Functional Mitral Regurgitation 
During systole, the LV shortens in the long axis, 
whereby the mitral annulus moves towards the apex. 
The annulus returns during diastole in an early and a 
late phase in patients with sinus rhythm: the early 
phase reflects the rate of myocardial relaxation; the late 
phase is the result of the atrial contraction [12, 46]. 
Mitral annular displacement reflects global long axis 
LVF [33, 43] and can be used as surrogate for LV 
longitudinal strain [47]. The velocity of the mitral 
annulus displacement does not depend on pressure 
gradients, as is the case for blood flows [46]. This 
velocity reflects the rate of change in LV long-axis 
dimension and LV volume, which on its turn is related 
to global LV function and to myocardial relaxation [33, 
48]. In a diseased LV, relaxation can become non-
uniform, which lessens the correlation between mitral 
annular velocity and global LV relaxation [46]. 
Velocities and amplitudes of the mitral annulus seem to 
be more sensitive for systolic LVF compared to LVEF. 
This mitral annular plane systolic excursion (MAPSE) 
has several components: longitudinal, rotational and 
translational. It decreases in patients with AS [17]. 
Some cut-off values have been determined. If it is 
below 7 or 8 mm, it indicates that LVEF is below 50%, 
a value of 10 mm or more is linked to a LVEF of at 
least 55%. It is doubtful, however if this relation is valid 
in LVH and hence, in most patients with AS. Moreover, 
MAPSE cannot detect small myocardial abnormalities 
[33]. Mitral DT or deceleration time of early LV filling 
velocity is an important parameter for stiffness of the 
LV. DT can be measured from the mitral annular 
excursion [12] and represents diastolic LV function. A 
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shortened DT during mitral inflow indicates a restrictive 
filling [8]. 
The E wave represents the early diastolic peak of 
trans-mitral flow [22, 46] and is determined by the 
pressure gradient between the LA and the LV. The 
latter is affected by LVF [14, 49]. Early diastolic filling 
increases in patients with AS [17, 18]. However, atrial 
dysfunction has to be taken into account [46]. The A 
wave represents late trans-mitral diastolic filling and is 
determined by the pressure gradient between LV and 
LA during late diastole. It increases in patients with AS 
and decreased relaxation of the LV [17, 2, 46]. In this 
condition, the mitral valve opens later. The emptying of 
the LA is delayed. At the start of its contraction, the LA 
is still relatively filled and the A wave increases. The A 
wave is affected by the compliance of the LV and the 
contractility of LA. The A wave can be valuable in 
patients whose E/E’ value is located between 8 and 15 
and in whom the LV filling pressure is difficult to predict 
[46]. The E/A ratio between early and late trans-mitral 
LV filling velocity [18, 50] serves as a parameter of 
diastolic dysfunction and decreases in patients with AS 
[17]. A decreased deceleration time or decreased E/A 
is specific for abnormal LV relaxation but not for 
changes of filling pressure. The latter also depends on 
the delay of the relaxation. When the LV relaxation 
worsens, the LV compliance decreases further. The LA 
pressure increases, which “overwhelms” the relaxation 
of the LV. When this occurs, the IRT shortens and E/A 
increases. It should be noted that with normal LVEF, 
mitral velocities correlate poorly with hemodynamics. 
Furthermore, velocities during early LV filling can 
misleadingly be normal in normal LV volumes but 
elevated LVEDP. One should be aware that with 
variable extent of LV relaxation, the pressure gradient 
between the LA and the LV varies for similar LA 
pressure. When the LV becomes stiffer, the mitral DT 
shortens: the filling of the LV decelerates more rapidly 
if the LA pressure remains constant [51, 52]. 
The early diastolic mitral annular motion E’, is 
related to recoil and relaxation of the LV and is 
independent from preload. It serves as indicator for 
diastolic dysfunction [14]: E’ reduces when LV 
relaxation is impaired, [48], such as in patients with AS 
[8, 17, 22, 53]. E’ is measured at the septal and the 
lateral side and corrects for the influence of myocardial 
relaxation on the trans-mitral flow E. Mitral annular 
calcification, which can be observed in patients with 
AS, is a confounding factor for E’. Moreover, age has 
also an effect. Combining the influence of the trans-
mitral driving pressure with myocardial relaxation by 
the ratio E/E’ is a better parameter [46] to estimate 
diastolic dysfunction [14] or LV filling pressure 
[22,48,53,54]. E/E’ is increased in patients with AS [17], 
at rest and during exercise, compared to healthy 
controls [22]. A value of 8 or less predicts normal mean 
LV diastolic pressure, while a value of 15 points to an 
increased mean diastolic LV pressure [46]. 
Functional mitral regurgitation (FMR) is rather 
common in patients with AS [55]. It is the consequence 
of tethering of the chordate tendineae during dilatation 
of the LV or of LVH. FMR can be graded from absent, 
mild, moderate to severe [5] and is associated with 
larger ventricles and with CHF. Patients with FMR have 
a tendency for more co-morbid conditions [55]. The 
close anatomical and physiological relationship, the so-
called aorto-mitral coupling could add to FMR in 
patients with AS [47]. There is a fibrous continuity 
between the mitral and the aortic valve [56]. Through 
this structure, AS might affect the dynamics of the 
mitral annulus. During LV systole, the normal mitral 
annulus contracts and pulls at the fibrous region, 
enlarging the aortic annular area. This facilitates 
systolic ejection. Conversely, during LV diastole, the 
mitral annular area expands. This improves LV filling. 
Hence, there is a mutual facilitation of the function of 
both valves [47]. FMR leads to a reduced torsion and 
recoil rate [36].  
The Changes at the Atrial and Pulmonary Venous 
Level Include Atrial Sizes and Strain 
The LA acts first, as a reservoir during the 
ventricular systole, before the opening of the mitral 
valve, second, as a conduit, between the opening of 
the mitral valve and the start of the atrial contraction, 
and third, as a pump, contributing to the LV end-
diastolic volume. Diastolic dysfunction of the LV leads 
to remodeling of the LA [7]. Filling pressures reflect 
Doppler based velocities and LA size reflects 
cumulative effects. The latter is also a predictor for 
adverse cardiac events, but this has to be considered 
in conjunction with the clinical status of the patient [57]. 
When the relaxation of the LV is impaired, the early 
diastolic AV gradient as well as the LA conduit volume 
decreases. In order to maintain LV end-diastolic 
volume, the pump and reservoir function of the LA have 
to increase. AS leads to considerable dysfunction, not 
only of the LV but also of the LA, irrespective of the 
degree of LVH [17]. The increase in LA pressure is 
necessary for an adequate filling of the stiffer LV and 
points to a more advanced stage. This results in an 
enlargement of the LA [45], a decreased atrial 
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contractile function and atrial arrhythmias such as 
postoperative AF [17,58]. This is not an innocent event 
[10, 17]. LA area has a significance in determining LV 
filling pressure [46]. Increased LA volume index (> 
40ml/m) is associated with LVH and increased LV 
end-diastolic pressure. LA volume index is of more 
importance compared to E/E’ and provides information 
“beyond the standard risk factors” [58]. 
PALS (peak atrial longitudinal strain) and PACS 
(peak atrial contraction strain) decrease in patients with 
AS [17]. Predictors for increase in global PALS are 
change of mean transvalvular gradient and the E/A 
ratio [17]. LA volume does not correlate well with LA 
strain. Therefore, other parameters are needed to 
detect dysfunction of the LA. First, the Frank-Starling 
mechanism (increase in size leading to an increase in 
output and maintenance of stroke volume) is also 
active in the LA, but when this relation is exceeded, the 
contractile function of the LA decreases. Second, the 
atrial muscle can be affected by the reflected waves 
during systole. This mechanical relationship is 
suggested by the reversal of LA volume after AVR. 
Hence, there is more needed than LVH and LV 
dysfunction to explain dyspnea and atrial fibrillation in 
patients with AS [17]. Early detection of changes in LA 
size and function in patients with AS can be helpful in 
the selection of patients for AVR as well as for the 
timing of the operation [17]. The atrium contributes to 
the LV filling. In small, hypertrophied and non-
compliant ventricles, this contribution becomes very 
important. Atrial fibrillation, especially with rapid LV 
response and shortened diastolic time will lead to 
symptoms in patients with AS [8]. The E/E’ ratio and 
MAPSE do not differ between patients with and without 
AF [17].  
Since there are no valves in the pulmonary veins, 
the flow waves of the atrium correspond with the 
pulmonary flow waves D, S and A. Therefore, anything 
that increases LA pressure will decrease the flow 
through the pulmonary vein and can even reverse this 
flow. An atrial reverse wave can be the result. Anything 
that decreases the LA pressure will increase the flow 
from the pulmonary veins into the LA. The peak D 
wave represents the peak diastolic flow velocity in the 
pulmonary veins, and indirectly the diastolic LVF [50]. 
In patients with an ambiguous E/E’ value between 8 
and 15, a pulmonary venous flow during atrial 
contraction exceeding the duration of the mitral flow 
with 30 msec. might give an indication of LV filling 
pressures [46]. The S wave represents the systolic flow 
velocity and is influenced by relaxation or compliance 
of the LA. The S/D is the ratio between the systolic and 
the diastolic flow velocity in the pulmonary veins and 
represents diastolic LVF [50]. A combination with 
pulmonary venous velocity might improve the 
diagnostic value of the mitral inflow E as representation 
of LV diastolic function [46]. The A wave corresponds 
with the atrial contraction. If the LV compliance has 
reduced, there is a large A wave in the pulmonary 
veins. However, if the LA fails mechanically, no A wave 
can be detected in the pulmonary veins.  
Effect of AVR on the LA and LV Parameters  
LVH regresses after AVR [6], but this regression is 
not always complete [22]. The size of the myocytes 
decreases, the extent of fibrosis does not [27-29]. 
Factors for persistent LVH are age and large LV end 
diastolic dimension [19]. Predictors for regression of 
LVH are baseline LVM, LA volume [39] and the Tei-
index [59]. Because of this incomplete regression, 
exercise induced LV filling pressure [23], longitudinal 
LV strain and function [17, 39, 40, 42, 43, 60], do not 
reverse fully. TSR recovers after AVR [37, 40], 
probably because of reduction of subendocardial 
ischemia [11]. However, changes in apical rotation do 
not, or in part, reverse after AVR [39,40]. The 
improvement of E/E’ after AVR is matter for debate: 
some observe a decrease [17] but without a complete 
normalization [22]. Others state that E/E’ does not 
improve. This indicates that after AVR, systolic LV 
function improves, but diastolic LV function does not 
[14]. For the LA parameter, the same debate exists [17, 
28, 61].  
CONCLUSION 
AS causes a remodeling of the complete left sided 
heart and the venous pulmonary circulation. The LV 
becomes stiff and fibrotic. The filling pressure 
increases and changes of the LV diastolic function 
occur. The LA enlarges and can become also 
dysfunctional. When the LVEF starts to drop, the 
changes in the LV might already be irreversible, even 
when the patient is still asymptomatic. A high number 
of mutually related and partly overlapping imaging and 
Doppler derived parameters have been developed in 
order to detect these early subclinical changes. These 
parameters might be helpful in more accurate timing of 
AVR and hence, improving postoperative results. The 
early stages of CHF might be called “diastolic”. When 
in a later stage LVEF drops, CHF could be called 
“systolic”. Although some consider both types of CHF 
as two separate disorders, it seems reasonable to 
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consider, both conditions of a continuum within the 
framework of AS: during the progress of the valve 
disease, the diastolic type can evolve into the systolic 
type. In patients with dyspnea and known AS with still 
preserved LVEF, increased volumes of LV and of LA, 
increased LV mass and increased E/E’ or other 
Doppler derived parameters can establish the 
diagnosis of diastolic CHF. Changes of these 
parameters seem only partially reversible by AVR. 
Early valve replacement, in a stage where these 
diastolic changes are still limited might improve the 
postoperative results. This requires an RCT in which 
the effect of timing of AVR on the postoperative results 
is studied. There are several limitations in this review: 
1) Due to the vast literature, inclusion of all relevant 
articles is impossible. The most relevant articles have 
been included, but this handpicking remains somehow 
arbitrary. 2) The manuscript is limited to physiological 
principles. Any indication to echocardiographic 
techniques and challenges as such have been omitted. 
3) Age has an effect on diastolic parameters. Since 
patients with AS are mostly elderly, this age related 
effect has to be taken into account: only values of 
patients over 60 years should be used as baseline 
parameters. 4) Moreover, in these patients, other 
conditions such as coronary artery disease, atrial 
fibrillation, mitral annular calcification, and 
atrioventricular block can have confounding effects on 
flow waves. 5) The effect of diastolic ventricular 
dysfunction on the pulmonary arterial pressure has not 
been included. 6) Finally, some more complicated 
parameters such as velocity-time integral of several 
waves have not been included.  
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